Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for Symptomatic Uterine Leiomyomas
NCT00219778Phase 2Terminated
- Sponsor
- CHU de Poitiers
- Start
- Dec 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in uterine leiomyoma, sponsored by CHU de Poitiers. Started Dec 2004; status: terminated.
02
Drugs
mifepristone
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT00219778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219778.